Cover Image
市場調查報告書

心臟去顫器的全球市場:各產品 (T-ICD,S-ICD,CRT-D,MED,AED,WCD) 、各終端用戶 (醫院,院前救護,公共使用,替代治療,居家醫療) - 市場機會分析及產業預測

Defibrillators Market by Product (T-ICDs, S-ICDs, CRT-D, MED, AED, WCD) and End-User (Hospitals, Prehospital, Public Access, Alternate Care, Home) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

出版商 Allied Market Research 商品編碼 370275
出版日期 內容資訊 英文 150 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
心臟去顫器的全球市場:各產品 (T-ICD,S-ICD,CRT-D,MED,AED,WCD) 、各終端用戶 (醫院,院前救護,公共使用,替代治療,居家醫療) - 市場機會分析及產業預測 Defibrillators Market by Product (T-ICDs, S-ICDs, CRT-D, MED, AED, WCD) and End-User (Hospitals, Prehospital, Public Access, Alternate Care, Home) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022
出版日期: 2016年08月01日 內容資訊: 英文 150 Pages
簡介

心臟去顫器 是為了給予有心室顫動,心律失常,無脈性心室心搏過速等危及生命的症狀之患者心臟治療性震擊所用。由於公共機關,民間機關的心臟去顫器設置擴大而推動了市場的成長。此外,技術進步和高齡化迅速,心臟疾病的發病率上升等對成長也有巨大幫助。

本報告提供全球心臟去顫器市場相關調查,彙整市場上各產品,終端用戶趨勢與各地區趨勢,2014∼2022年的預測,及加入此市場的主要企業簡介等資料。

第1章 簡介

第2章 摘要整理

第3章 市場概要

  • 市場定義和範圍
  • 主要調查結果
  • 波特五力分析
  • 市場佔有率分析
  • 市場趨勢
    • 促進要素
    • 阻礙要素
    • 機會

第4章 各產品市場

  • 概要
  • 埋入式心臟心臟去顫器
  • 體外去顫器

第5章 各終端用戶市場

  • 概要
  • 醫院
  • 院前救護
  • 公共使用市場
  • 替代治療市場
  • 居家醫療

第6章 各地區市場

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 南美·中東·非洲

第7章 企業簡介

  • 旭化成株式會社
  • Stryker Corporation
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Philips Healthcare (A Division of Koninklijke Philips N.V.)
  • LivaNova PLC
  • Medtronic plc
  • St. Jude Medical, Inc.
  • Cardiac Science Corporation
  • 日本光電工業株式會社

圖表

目錄
Product Code: LI 161434

Cover Image Defibrillators are devices used to deliver therapeutic shock to a patient's heart in life-threatening conditions such as ventricular fibrillation, cardiac arrhythmia, and pulseless ventricular tachycardia. The defibrillation procedure encompasses delivery of an electric shock to the heart, which depolarizes heart muscles and restores its normal electric impulse. Growing focus towards public access defibrillator (PAD) by the public & private organizations, along with the key players, has fuelled the market growth. Other factors such as technologically advanced defibrillator devices, rapidly growing geriatric population with elevated risk of targeted diseases, and increasing incidence of cardiac diseases are driving the market growth. However, frequent product recalls, increasing pricing pressure on players and lack of awareness about sudden cardiac arrest (SCA) are restraining the growth of this market.

The world defibrillators market is segmented on the basis of product, end user, and geography. On the basis of product, the world defibrillator market is further segmented into implantable defibrillators and external defibrillators. Implantable defibrillators are further categorized into cardiac resynchronisation therapy- defibrillator (CRT-D), transvenous implantable cardioverter defibrillator (T-ICDs) and subcutaneous implantable cardioverter defibrillator (S-ICDs). Among these, the T-ICDs segment dominates the overall ICD market owing to higher precision and targeted functioning. In addition, external defibrillators segment is further categorized into manual external defibrillator, automated external defibrillator (AEDs), and wearable cardioverter defibrillator (WCDs).

On the basis of end user, the defibrillator market is segmented into hospitals, prehospital, public access market, alternative care market, and home. Geographically, the market is segmented across four major regions such as North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in the defibrillators market. The growth in this region is mainly due to factors such as product innovations, growing number of public defibrillation programs, and rising prevalence of chronic diseases. In addition, the Asia-Pacific region is expected to emerge as the area with maximum growth potential due to the growing focus of key players in emerging economies, improving healthcare infrastructure, and rising number of cardiovascular diseases.

The report provides a comprehensive analysis of the key players operating in the world defibrillators market such as Asahi Kasei Corporation, Stryker Corporation, Biotronik SE & Co. KG, Boston Scientific Corporation, Philips Healthcare, LivaNova PLC, Medtronic plc, Cardiac Science Corporation, Nihon Kohden Corporation, and St. Jude Medical, Inc.

Key Benefits of the Report

  • The study provides an in-depth analysis of the world neuromodulation market with current trends and future estimations to elucidate the imminent investment pockets.
  • The report provides a quantitative analysis from 2014 to 2022, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • The report provides actual historical figures for 2014 and 2015 and provides Y-o-Y forecasts for 2016 to 2022, considering 2015 as base.
  • Extensive analysis by product helps in understanding the various types of devices used for the treatment of neurological diseases and other related conditions.
  • Competitive intelligence highlights the business practices followed by leading players across various regions.
  • SWOT analysis studies the internal environment of the leading companies for strategy formulation.

KEY MARKET SEGMENTS:

The world defibrillators market is segmented into product, end user, and geography.

By Product

  • Implantable Defibrillators
  • Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
  • Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)
  • Cardiac Resynchronization Therapy- Defibrillator (CRT-D)
  • External Defibrillators
  • Manual External Defibrillator
  • Automated External Defibrillator (AEDs),
  • Wearable Cardioverter Defibrillator (WCDs).

By End User

  • Hospitals
  • Pre-hospitals
  • Public Access market
  • Alternate Care Market
  • Home

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Argentina
    • Egypt
    • Israel
    • South Africa

Table of Contents

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Benefits
  • 1.3. Key Market Segments
  • 1.4. Research Methodology
    • 1.4.1. Secondary Research
    • 1.4.2. Primary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market Definition And Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. High competition and fragmented market moderate the power of the suppliers
    • 3.3.2. Scattered and large number of buyers moderate their bargaining power
    • 3.3.3. High capital investment moderates the threat of new entrants
    • 3.3.4. High intensity of rivalry
    • 3.3.5. Unavailability of substitutes lowers the threat of substitutes
  • 3.4. Market Share Analysis, 2015
  • 3.5. Market Dynamics
    • 3.5.1. Drivers
      • 3.5.1.1. Growing incidence of sudden cardiac arrest (SCA) and cardiovascular diseases across the globe
      • 3.5.1.2. Technological advancements in defibrillators
      • 3.5.1.3. Increasing patient awareness
      • 3.5.1.4. High presence of unmet medical needs
    • 3.5.2. Restraints
      • 3.5.2.1. Limited insurance coverage and high cost of the defibrillators
      • 3.5.2.2. preference of drugs over defibrillators
    • 3.5.3. Opportunities
      • 3.5.3.1. Lucrative opportunities in emerging economies
      • 3.5.3.2. Development of new MRI-labeled devices

CHAPTER 4: WORLD DEFRIBILLATORS MARKET, BY PRODUCT

  • 4.1. Overview
  • 4.2. Implantable Cardioverter Defibrillators (ICDs)
    • 4.2.1. Key Market Trends
    • 4.2.2. Key Growth Factors and Opportunities
    • 4.2.3. Market Size and Forecast
      • 4.2.3.1. Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
        • 4.2.3.1.1. MARKET SIZE AND FORECASTS
      • 4.2.3.2. Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)
        • 4.2.3.2.1. MARKET SIZE AND FORECASTS
      • 4.2.3.3. CRT with pacemaker and ICD function (CRT-D)
        • 4.2.3.3.1. MARKET SIZE AND FORECASTS
  • 4.3. External Defibrillator
    • 4.3.1. Key Market Trends
    • 4.3.2. Key Growth Factors and Opportunities
    • 4.3.3. Market Size and Forecast
    • 4.3.4. Manual External Defibrillator
      • 4.3.4.1. Market size and forecast
    • 4.3.5. Automated External Defibrillator (AEDs)
      • 4.3.5.1. Market size and forecast
      • 4.3.5.2. Semi-automated EXTERNAL DEFIBRILLATOR
        • 4.3.5.2.1. MARKET SIZE AND FORECAST
      • 4.3.5.3. Fully automated External Defibrillator
        • 4.3.5.3.1. MARKET SIZE AND FORECAST
    • 4.3.6. Wearable Cardioverter Defibrillator (WCDs)
      • 4.3.6.1. Market size and forecast

CHAPTER 5: WORLD DEFRIBILLATORS MARKET, BY END USER

  • 5.1. Overview
    • 5.1.1. Market Size and Forecast
  • 5.2. Hospitals
    • 5.2.1. Market Size and Forecast
  • 5.3. Prehospital
    • 5.3.1. Market Size and Forecast
  • 5.4. Public Access Market
    • 5.4.1. Market Size and Forecast
  • 5.5. Alternate Care Market
    • 5.5.1. Market Size and Forecast
  • 5.6. Home
    • 5.6.1. Market Size and Forecast

CHAPTER 6: DEFIBRILLATORS MARKET, BY GEOGRAPHY, 2015-2022

  • 6.1. Overview
    • 6.1.1. Market Size and Forecast
  • 6.2. North America
    • 6.2.1. Key Market Trends
    • 6.2.2. Key Growth Factors and Opportunities
    • 6.2.3. Market Size and Forecast
      • 6.2.3.1. U.S. Market size and forecast
      • 6.2.3.2. Canada Market size and forecast
      • 6.2.3.3. Mexico Market size and forecast
  • 6.3. Europe
    • 6.3.1. Key Market Trends
    • 6.3.2. Key Growth Factors and Opportunities
    • 6.3.3. Market Size and Forecast
      • 6.3.3.1. U.K. Market size and forecast
      • 6.3.3.2. France Market size and forecast
      • 6.3.3.3. Germany Market size and forecast
      • 6.3.3.4. Italy Market size and forecast
      • 6.3.3.5. Spain Market size and forecast
      • 6.3.3.6. Rest of Europe Market size and forecast
  • 6.4. Asia-Pacific
    • 6.4.1. Key Market Trends
    • 6.4.2. Key Growth Factors and Opportunities
    • 6.4.3. Market Size and Forecast
      • 6.4.3.1. Japan Market size and forecast
      • 6.4.3.2. China Market size and forecast
      • 6.4.3.3. India Market size and forecast
      • 6.4.3.4. Australia Market size and forecast
      • 6.4.3.5. Rest of Asia-Pacific Market size and forecast
  • 6.5. LAMEA
    • 6.5.1. Key Market Trends
    • 6.5.2. Key Growth Factors and Opportunities
    • 6.5.3. Market Size and Forecast
      • 6.5.3.1. Brazil Market size and forecast
      • 6.5.3.2. Argentina Market size and forecast
      • 6.5.3.3. Egypt Market size and forecast
      • 6.5.3.4. Israel Market size and forecast
      • 6.5.3.5. South Africa Market size and forecast

CHAPTER 7: COMPANY PROFILES

  • 7.1. Asahi Kasei Corporation
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Operating Business Segments
    • 7.1.4. Business Performance
    • 7.1.5. Key Strategic Moves and Developments
    • 7.1.6. SWOT Analysis
  • 7.2. Stryker Corporation
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Operating Business Segments
    • 7.2.4. Business Performance
    • 7.2.5. Key Strategic Moves and Development
    • 7.2.6. SWOT Analysis
  • 7.3. Biotronik SE & Co. KG
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Operating Business Segments
    • 7.3.4. Key Strategic Moves & Developments
    • 7.3.5. SWOT Analysis
  • 7.4. Boston Scientific Corporation
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Operating Business Segments
    • 7.4.4. Business Performance
    • 7.4.5. Key Strategic Moves and Developments
    • 7.4.6. SWOT Analysis
  • 7.5. Philips Healthcare (A Division of Koninklijke Philips N.V.)
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Operating Business Segments Overview
    • 7.5.4. Business Performance
    • 7.5.5. SWOT Analysis
  • 7.6. LivaNova PLC
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Operating Business Segments
    • 7.6.4. Business Performance
    • 7.6.5. Key Strategic Moves and Developments
    • 7.6.6. SWOT Analysis
  • 7.7. Medtronic plc
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Operating Business Segments
    • 7.7.4. Business Performance
    • 7.7.5. Key Strategic Moves and Developments
    • 7.7.6. SWOT Analysis
  • 7.8. St. Jude Medical, Inc.
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Operating Business Segments
    • 7.8.4. Business Performance
    • 7.8.5. Key Strategic Moves and Developments
    • 7.8.6. SWOT Analysis
  • 7.9. Cardiac Science Corporation
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Operating Business Segments
    • 7.9.4. Key Strategic Moves and Developments
    • 7.9.5. SWOT Analysis
  • 7.10. NIHON KODEN CORPORATION
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Operating Business Segments
    • 7.10.4. Business Performance
    • 7.10.5. Key Strategic Moves and Developments
    • 7.10.6. SWOT Analysis

List of Tables

  • TABLE 1: WORLD DEFIBRILLATOR MARKET, BY PRODUCT TYPE, VOLUME, 2014-2022 (UNIT)
  • TABLE 2: WORLD DEFIBRILLATOR MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
  • TABLE 3: WORLD ICDS MARKET, BY TYPE, VOLUME, 2014-2022 (UNIT)
  • TABLE 4: WORLD ICDS MARKET, BY TYPE, 2014-2022 ($MILLION)
  • TABLE 5: WORLD ICDS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 6: WORLD EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, VOLUME, 2014-2022 (UNIT)
  • TABLE 7: WORLD EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2014-2022 ($MILLION)
  • TABLE 8: EXTERNAL DEFIBRILLATORS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 9: WORLD AUTOMATED EXTERNAL DEFIBRILLATORS (AEDS) MARKET, BY TYPE, 2015-2022 ($MILLION)
  • TABLE 10: WORLD DEFIBRILLATORS MARKET, BY END USER, 2014-2022 ($MILLION)
  • TABLE 11: WORLD DEFIBRILLATORS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 12: WORLD DEFIBRILLATORS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
  • TABLE 13: WORLD: DEFIBRILLATORS MARKET, BY END USER, 2014-2022 ($MILLION)
  • TABLE 14: NORTH AMERICA: DEFIBRILLATORS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
  • TABLE 15: NORTH AMERICA: DEFIBRILLATORS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
  • TABLE 16: NORTH AMERICA: DEFIBRILLATORS MARKET, BY END USER, 2014-2022 ($MILLION)
  • TABLE 17: NORTH AMERICA: ICDS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
  • TABLE 18: NORTH AMERICA: EXTERNAL DEFIBRILLATOR MARKET, BY COUNTRY, 2014-2022 ($MILLION)
  • TABLE 19: EUROPE: DEFIBRILLATORS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
  • TABLE 20: EUROPE: DEFIBRILLATORS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
  • TABLE 21: EUROPE: DEFIBRILLATORS MARKET, BY END USER, 2014-2022 ($MILLION)
  • TABLE 22: EUROPE: ICDS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
  • TABLE 23: EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
  • TABLE 24: ASIA-PACIFIC: DEFIBRILLATORS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
  • TABLE 25: ASIA-PACIFIC: DEFIBRILLATORS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
  • TABLE 26: ASIA-PACIFIC: DEFIBRILLATORS MARKET, BY END USER, 2014-2022 ($MILLION)
  • TABLE 27: ASIA-PACIFIC: ICDS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
  • TABLE 28: ASIA-PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
  • TABLE 29: LAMEA: DEFIBRILLATORS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
  • TABLE 30: LAMEA: DEFIBRILLATORS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
  • TABLE 31: LAMEA: DEFIBRILLATORS MARKET, BY END USER, 2014-2022 ($MILLION)
  • TABLE 32: LAMEA: ICDS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
  • TABLE 33: LAMEA: EXTERNAL DEFIBRILLATORS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
  • TABLE 34: ZOLL MEDICAL CORPORATION: COMPANY SNAPSHOT
  • TABLE 35: STRYKER CORPORATION: COMPANY SNAPSHOT
  • TABLE 36: BIOTRONIK: COMPANY SNAPSHOT
  • TABLE 37: BIOTRONIK: OPERATING SEGMENTS
  • TABLE 38: BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 39: BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
  • TABLE 40: PHILIPS HEALTHCARE: SNAPSHOT
  • TABLE 41: TABLE 2 PHILIPS: OPERATING SEGMENTS
  • TABLE 42: LIVANOVA: COMPANY SNAPSHOT
  • TABLE 43: LIVANOVA: OPERATING SEGMENTS
  • TABLE 44: MEDTRONIC: COMPANY SNAPSHOT
  • TABLE 45: MEDTRONIC: OPERATING SEGMENTS
  • TABLE 46: ST. JUDE MEDICAL: COMPANY SNAPSHOT
  • TABLE 47: ST. JUDE MEDICAL: PRODUCT CATEGORIES
  • TABLE 48: CARDIAC SCIENCE CORPORATION: COMPANY SNAPSHOT
  • TABLE 49: CARDIAC SCIENCE CORPORATION: OPERATING SEGMENTS
  • TABLE 50: NIHON KOHDEN: COMPANY SNAPSHOT
  • TABLE 51: NIHON KOHDEN: OPERATING SEGMENTS

List of Figures

  • FIG. 1: TOP INVESTMENT POCKETS IN WORLD DEFIBRILLATORS MARKET
  • FIG. 2: TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, 2014-2016
  • FIG. 3: TOP WINNING STRATEGIES: NATURE AND TYPE
  • FIG. 4: PORTER'S FIVE FORCES ANALYSIS
  • FIG. 5: MARKET SHARE ANALYSIS, 2015
  • FIG. 6: TOP IMPACTING FACTORS: WORLD DEFIBRILLATORS MARKET
  • FIG. 7: WORLD TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (T-ICDS) MARKET, 2014-2022 ($MILLION)
  • FIG. 8: WORLD SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (S-ICDS) MARKET, 2014-2022 ($MILLION)
  • FIG. 9: WORLD CRT-D DEFRIBILLATORS MARKET, 2014-2022 ($MILLION)
  • FIG. 10: WORLD MANUAL EXTERNAL DEFIBRILLATOR MARKET, 2014-2022 ($MILLION)
  • FIG. 11: WORLD SEMI-AUTOMATED EXTERNAL DEFIBRILLATOR (AED) MARKET, 2014-2022 ($MILLION)
  • FIG. 12: WORLD FULLY-AUTOMATED DEFIBRILLATOR MARKET, 2014-2022 ($MILLION)
  • FIG. 13: WORLD WEARABLE EXTERNAL DEFIBRILLATOR MARKET, 2014-2022 ($MILLION)
  • FIG. 14: WORLD DEFIBRILLATORS MARKET FOR HOSPITALS, 2014-2022 ($MILLION)
  • FIG. 15: WORLD DEFIBRILLATORS MARKET FOR PREHOSPITAL, 2014-2022 ($MILLION)
  • FIG. 16: WORLD DEFIBRILLATORS MARKET FOR PUBLIC ACCESS DEFIBRILLATION, 2014-2022 ($MILLION)
  • FIG. 17: WORLD DEFIBRILLATORS MARKET FOR ALTERNATE CARE MARKET, 2014-2022 ($MILLION)
  • FIG. 18: WORLD DEFIBRILLATORS MARKET FOR HOME, 2014-2022 ($MILLION)
  • FIG. 19: U.S. DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
  • FIG. 20: CANADA DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
  • FIG. 21: MEXICO DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
  • FIG. 22: U.K. DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
  • FIG. 23: FRANCE DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
  • FIG. 24: GERMANY DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
  • FIG. 25: ITALY DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
  • FIG. 26: SPAIN DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
  • FIG. 27: REST OF EUROPE DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
  • FIG. 28: JAPAN DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
  • FIG. 29: CHINA DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
  • FIG. 30: INDIA DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
  • FIG. 31: AUSTRALIA DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
  • FIG. 32: REST OF ASIA-PACIFIC DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
  • FIG. 33: BRAZIL DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
  • FIG. 34: ARGENTINA DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
  • FIG. 35: EGYPT DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
  • FIG. 36: ISRAEL DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
  • FIG. 37: SOUTH AFRICA DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
  • FIG. 38: ASAHI KASEI CORPORATION: NET REVENUE, 2012-2014($MILLION)
  • FIG. 39: ASAHI KASEI CORPORATION: REVENUE, BY SEGMENT, 2015 (%)
  • FIG. 40: ASAHI KASEI CORPORATION: HEALTHCARE GROUP REVENUE, BY SUBSEGMENT, 2015 (%)
  • FIG. 41: ASAHI KASEI CORPORATION: SWOT ANALYSIS
  • FIG. 42: STRYKER CORPORATION: NET SALES, 2013-2015 ($MILLION)
  • FIG. 43: STRYKER CORPORATION: REVENUE, BY SEGMENT, 2015 (%)
  • FIG. 44: STRYKER CORPORATION: REVENUE, BY GEOGRAPHY, 2015 (%)
  • FIG. 45: STRYKER CORPORATION: SWOT ANALYSIS
  • FIG. 46: BIOTRONIK: SWOT ANALYSIS
  • FIG. 47: BOSTON SCIENTIFIC CORPORATION: NET SALES, 2013-2015, ($MILLION)
  • FIG. 48: BOSTON SCIENTIFIC CORPORATION: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
  • FIG. 49: BOSTON SCIENTIFIC CORPORATION: RHYTHM MANAGEMENT REVENUE, BY SUBSEGMENT, 2015 (%)
  • FIG. 50: BOSTON SCIENTIFIC CORPORATION: REVENUE, BY GEOGRAPHY, 2015 (%)
  • FIG. 51: BOSTON SCIENTIFIC CORPORATION: SWOT ANALYSIS
  • FIG. 52: PHILIPS: REVENUE, 2013-2015 ($MILLION)
  • FIG. 53: PHILIPS: REVENUE, BY SEGMENTS, 2015 (%)
  • FIG. 54: PHILIPS: HEALTHCARE REVENUE, BY SUBSEGMENT, 2015 (%)
  • FIG. 55: PHILIPS: REVENUE, BY GEOGRAPHY, 2015 (%)
  • FIG. 56: PHILIPS HEALTHCARE: SWOT ANALYSIS
  • FIG. 57: LIVANOVA: NET SALES, 2013-2015 ($MILLION)
  • FIG. 58: LIVANOVA: REVENUE, BY BUSINESS SEGMENTS, 2015 (%)
  • FIG. 59: LIVANOVA: REVENUE, BY GEOGRAPHY, 2015 (%)
  • FIG. 60: LIVANOVA: REVENUE, BY GEOGRAPHY, 2015 (%)
  • FIG. 61: LIVANOVA: SWOT ANALYSIS
  • FIG. 62: MEDTRONIC: NET SALES, 2013-2015 ($MILLION)
  • FIG. 63: MEDTRONIC: REVENUE, BY SEGMENT, 2015 (%)
  • FIG. 64: MEDTRONIC: CARDIAC AND VASCULAR GROUP REVENUE, BY SUBSEGMENT, 2015 (%)
  • FIG. 65: MEDTRONIC: SWOT ANALYSIS
  • FIG. 66: ST. JUDE MEDICAL: NET SALES, 2013-2015 ($MILLION)
  • FIG. 67: ST. JUDE MEDICAL: REVENUE, BY PRINCIPLE PRODUCT CATEGORY, 2015 (%)
  • FIG. 68: ST. JUDE MEDICAL: REVENUE, BY GEOGRAPHY, 2015 (%)
  • FIG. 69: ST. JUDE MEDICAL: SWOT ANALYSIS
  • FIG. 70: CARDIAC SCIENCE CORPORATION: SWOT ANALYSIS
  • FIG. 71: NIHON KODEN: REVENUE, 2013-2015($MILLION)
  • FIG. 72: NIHON KODEN: REVENUE, BY SEGMENTS, 2015(%)
  • FIG. 73: NIHON KODEN: REVENUE, BY GEOGRAPHY, 2015(%)
  • FIG. 74: NIHON KOHDEN: SWOT ANALYSIS
Back to Top